HepaFat-Scan is a magnetic resonance imaging (MRI)-based technology for the non-invasive measurement of liver fat. It provides a reliable measure of volume percentage of liver fat for screening, diagnosis, treatment planning and monitoring of patients in a variety of clinical settings. What Does HepaFat-Scan Offer You? A non-invasive – safe and painless alternative to liver …
Potential Clinical Applications Gastroenterology and Hepatology Applications Initial workup for NAFLD diagnosis and for patient education and counselling. Liver fat analysis on patients already being screened or monitored for fibrosis or cirrhosis. Recent research indicates that patients with NAFLD and NASH can develop liver cancer without progressing through cirrhosis. Surgical Applications Scanning of patients with …
Non-alcoholic fatty liver disease (NAFLD) is a name that is given to a range of liver disorders associated with the presence of too much fat in the liver. Steatosis is a mild form of fatty liver. In some patients with steatosis, inflammation of the liver may occur with resultant hepatitis called non-alcoholic steatohepatitis (NASH). Risk …
INVESTORS
SUPPORT
PATIENTS
PHYSICIANS